A bivalent remipede toxin promotes calcium release via ryanodine receptor activation

Maxwell, Michael J.; Thekkedam, Chris; Lamboley, Cedric; Chin, Yanni K.-Y.; Crawford, Theo; Smith, Jennifer J.; Liu, Junyu; Jia, Xinying; Vetter, Irina; Laver, Derek R.; Launikonis, Bradley S.; Dulhunty, Angela; Undheim, Eivind A. B.; Mobli, Mehdi

doi:10.1038/s41467-023-36579-w

Download PDF

Article
Open access
Published: 23 February 2023

A bivalent remipede toxin promotes calcium release via ryanodine receptor activation

Nature Communications volume 14, Article number: 1036 (2023) Cite this article

2294 Accesses
3 Citations
7 Altmetric
Metrics details

Subjects

Abstract

Multivalent ligands of ion channels have proven to be both very rare and highly valuable in yielding unique insights into channel structure and pharmacology. Here, we describe a bivalent peptide from the venom of Xibalbanus tulumensis, a troglobitic arthropod from the enigmatic class Remipedia, that causes persistent calcium release by activation of ion channels involved in muscle contraction. The high-resolution solution structure of φ-Xibalbin3-Xt3a reveals a tandem repeat arrangement of inhibitor-cysteine knot (ICK) domains previously only found in spider venoms. The individual repeats of Xt3a share sequence similarity with a family of scorpion toxins that target ryanodine receptors (RyR). Single-channel electrophysiology and quantification of released Ca²⁺ stores within skinned muscle fibers confirm Xt3a as a bivalent RyR modulator. Our results reveal convergent evolution of RyR targeting toxins in remipede and scorpion venoms, while the tandem-ICK repeat architecture is an evolutionary innovation that is convergent with toxins from spider venoms.

Structural basis for voltage-sensor trapping of the cardiac sodium channel by a deathstalker scorpion toxin

Article Open access 04 January 2021

Molecular architecture of black widow spider neurotoxins

Article Open access 29 November 2021

A family of orthologous proteins from centipede venoms inhibit the hKir6.2 channel

Article Open access 01 October 2019

Introduction

Natural products are an important source of bioactive molecules, used widely in the development of therapeutics and as selective ligands in studies of physiology¹. Among natural products, venom-derived peptide toxins have emerged as important ion channel ligands due to their high potency and selectivity². Ion channels are the fastest cellular signaling elements, and it is therefore not surprising that many venomous animals have convergently evolved to target these proteins to elicit a rapid physiological response^2,3.

Venom peptides that target ion channels typically fold into highly ordered tertiary structures — often referred to as domains — that are stabilized through the formation of multiple intra-molecular disulfide bonds⁴. The stabilizing disulfide bonds enable hypervariability of non-cysteine residues which diversify and refine toxin function, resulting in toxin-receptor interactions with exceptionally high specificity and potency⁵. Indeed, through evolutionary processes, activity-based structural refinement has led to multiple independent lineages of toxins that target the same receptors, resulting in structural convergence of these peptides⁶. Exploring the interactions of these relatively large (peptidic) ligands with their receptors has revealed them to stabilize specific receptor states, thereby improving our understanding of ion channel function and in some cases providing leads for developments of new therapeutics and agrochemicals^7,8,9. One such domain that is commonly found in animal venoms is the inhibitor cystine knot (ICK), which consists of an anti-parallel β-sheet stabilized by cysteines in a pseudo-knot arrangement that makes it both stable and highly tolerant to inter-cysteine sequence variability^5,10.

There is emerging evidence that some venomous organisms produce toxins with multiple repeating peptide domains that have a multivalent mode-of-action¹¹. Several two-domain ‘tandem repeat toxins’ have been described that contain two ICK domains, all from the venoms of (distantly related) spiders^12,13,14. While the two “double-knot” toxins that have been studied in detail target different receptors—one is a capsaicin receptor (TRPV1) agonist while the other is an acid sensing ion channel (ASIC1a) inhibitor^12,13 — they both display remarkable receptor avidity driven by a bivalent receptor binding mode¹⁵. The evolution of tandem repeats of peptide domains adds an intriguing new dimension to venom evolution, where the emerging quaternary structure can further modulate the potency and specificity of existing toxin domains. It also raises the question as to whether such multidomain toxins are evolutionary rarities, or whether animal venoms are indeed potentially rich sources of this emerging class of bivalent and pharmacologically interesting peptides.

Here, we present the characterization of a double-knot toxin from the venom of a remipede, Xibalbanus tulumensis, and show that it targets ryanodine receptors (RyRs). Remipedes are a recently discovered class of crustaceans¹⁶, and while proteomic studies have revealed their venoms to contain high toxin diversity, little is known of the evolution or pharmacology of these toxins¹⁷. We provide structural and functional characterization of φ-Xibalbin3-Xt3a (henceforth Xt3a), showing that it assumes a well-structured tandem domain arrangement — including an unusual, disordered N-terminal tail — and that it displays remarkable potency and avidity towards RyRs. Our results provide insight into remipede venom pharmacology and provide intriguing examples of convergent evolutionary innovation of molecular structure and function across multiple venomous lineages.

Results

Xt3a identified as a putative tandem repeat Ryanodine receptor modulator

The remarkable pharmacology of tandem-repeat toxins led us to devise a data-mining approach to identify uncharacterised bivalent toxins. First, we extracted all secreted protein sequences from UniProtKB; a database of protein sequence information¹⁸. Next a Secreted Cysteine-rich REpeat Protein (SCREP) processing algorithm (SPA) was employed to identify the existence of repeating cysteine-rich domains, by segmenting individual sequences and performing an iterative BLAST function¹⁹, thereby locating homologous intra-sequence regions¹¹. The resulting output contains a large amount of putative SCREPs (121,856) sequences with a high degree of structural and taxonomic diversity^11,20. We then used an annotated dataset of venom peptides from UniProt known as Tox-Prot^21,22, to further identify putative bioactive SCREPs based on their sequence identity to known toxins, resulting in 10,176 putative ion channel-targeting SCREPs showing similarity to 494 different single domain toxins. Among these we identified three double-ICK SCREPs (Xt1a-3a), which were originally identified by analysis of protein sequences translated from venom gland transcriptomics of the remipede Xibalbanus tulumensis¹⁷. Xt3a, an 82-residue peptide, was selected due to the high level of sequence similarity it shares with imperatoxin-A (IpTxA), a member of the calcin family of scorpion derived ICK toxins. The calcins are known to modulate activity of the intracellularly located ryanodine receptors (RyR), which are responsible for Ca²⁺ release within both skeletal and cardiac muscle^23,24, as well as in many neuronal cells²⁵. The C-terminal domain of Xt3a (Xt3a-D2) contains 3 of 6 analogous residues previously identified as critical for the activity of IpTxA (Fig. 1a), an important feature shared across all calcins^26,27.

**Fig. 1: Xt3a activates ryanodine receptors (RyRs) in a similar way to other toxins in the calcin family.**

Xt3a is a potent and selective RyR modulator

Xt3a was produced recombinantly as an MBP fusion protein in E. coli, using a periplasmic expression method²⁸, and after cleavage from the fusion tag, HPLC purification revealed a dominant, oxidatively folded, toxin isoform. The purified peptide was used in single channel electrophysiology recordings where RyR1 or RyR2 channels were inserted into a lipid bilayer as described previously²⁹. Average channel open probabilities (P_O) of RyR1 (relative to baseline levels prior to the addition of toxin) demonstrate significant changes in all Xt3a concentrations tested over the range 10 pM to 1 µM (Fig. 1 and Supplementary Figs. 1–4). High affinity activation of RyR1 at Xt3a concentrations up to 10 nM led to an increase in full conductance channel openings (Fig. 1). At higher Xt3a concentrations (0.1–1 µM), we observed a decline in P_O by ~50% compared with 10 nM Xt3a and a reduction in full conductance openings (Supplementary Figs. 1–2), indicating a secondary inhibitory effect. This secondary effect of reducing channel openings from full to half conductance is reminiscent of the IpTxA induced RyR1 substate²⁹. In contrast to the significant effects of Xt3a towards RyR1, RyR2 channels did not show any consistent changes in openings to the maximum conductance at Xt3a concentrations ranging from 1 nM to 1 μM (Fig. 1). RyR2 channels exhibited both low and high base level activity in the presence of 1 μM Ca²⁺ concentrations (Supplementary Figs. 1–2). However, neither the low or high activity channels (Supplementary Fig. 1c and d, respectively) responded in any significant manner to exposure to Xt3a, with the exception of a weak trend towards increased activity with 1 nM and 10 nM concentrations (Fig. 1c). These data indicate presence of low affinity inhibition that partially masks the high affinity activation, suggesting two separate binding sites. An additional effect observed was a voltage-dependent promotion of channel substate activity by Xt3a – being greater at −40 mV (Supplementary Fig. 3) than at +40 mV (see Fig. 1 and Supplementary Figs. 1–3) and greater in the presence of nanomolar concentrations of Xt3a in RyR1 than in RyR2; a characteristic effect previously observed with both IpTxA and ryanodine^29,30.

The specificity of Xt3a was assessed by performing assays against common toxin targets. Addition of Xt3a (3 µM) did not elicit an increase in intracellular Ca²⁺ in SH-SY5Y neuroblastoma cells expressing a range of ion channels and G protein-coupled receptors^31,32,33,34 (Supplementary Fig. 5). Moreover, Xt3a (3 µM) did not inhibit Ca²⁺ responses elicited by activation of endogenously expressed α7 nAChR, α3-containing nAChR, Ca_V1.3, Ca_V2.2, Na_V1.2 and Na_V1.7 channels (Supplementary Fig. 5b).

Xt3a is a double-ICK peptide with a semi-rigid domain linker

The double-ICK architecture of Xt3a was confirmed by producing a uniformly ¹³C and ¹⁵N isotope enriched Xt3a sample, which was used to generate an exhaustive set of heteronuclear NMR experiments (see Materials and Methods). The high-resolution structure, solved using ~1500 experimental constraints (Supplementary Table 1), reveals two independently folded domains separated in space by a peptide linker. The two domains adopt a back-to-back orientation (Fig. 2a) – where the two ICKs are translated 180° about two orthogonal axes. This quaternary domain configuration does not result in clear inter-domain dipolar couplings (NOEs); however, the fold was confirmed by a network of clear dipolar couplings along the linker, further stabilized by a covalent bond formed between a cysteine flanking the linker region and a cysteine in the second domain, forming an “m” shaped turn along the backbone (Fig. 2b and c).

**Fig. 2: Solution structure of the double-knot remipede toxin Xt3a.**

The structure calculations also revealed that the N-terminal region is disordered (residues 1–12) (Fig. 2d). This region contains several hydrophobic residues (A2-V3-L4-W5) perhaps indicating a potential role for membrane binding. We therefore performed NMR titration experiments to assess the binding of ¹⁵N Xt3a against cyclized nanodiscs containing zwitterioninc lipids. We found no evidence of specific binding to the bilayer, while several regions appear to weakly and non-specifically bind to the nanodiscs (Supplementary Fig. 6). These regions may point to potential hydrophobic binding interfaces involved in protein-protein interactions, most notably involving V26. This is contrary to outcome of similar experiments using known membrane active peptides^35,36.

The indication of a dynamic N-terminal region and the presence of a rigid and short inter-ICK linker prompted us to further investigate the dynamics of the peptide using ¹⁵N spin relaxation studies (Fig. 2d and Supplementary Fig. S7). The N-terminal region shows clear disorder as indicated by low or negative heteronuclear NOE ratios. The linker region shows NOE values closer to but lower than those of the structured regions of the peptide, indicating that the linker is not completely rigid. This observation makes the Xt3a linker more rigid than that of DkTx but less so than the linker of Hi1a. These results indicate that the Xt3a linker more closely resembles the linker of Hi1a than DkTx^12,13. Furthermore, we find that while the N-terminal ICK-domain appears to be overall less ordered (on a fast time-scale) than the C-terminal ICK domain, the R1 and R2 rates are in a similar range for the two domains, indicating that these share a common correlation time – consistent with the short and semi-rigid linker. The N-terminal tail, on the other hand, appears to reorient in solution largely independently of the other two domains, consistent with the observed disorder.

Xt3a induces a persistent RyR response

The two previously reported venom peptides with a tandem repeat ICK structure — the spider toxins DkTx and Hi1a — both display high avidity, evidenced by persistent activity during washout from their respective ion channel targets, TRPV1 and ASIC1a respectively. To examine if Xt3a displays a similar high avidity towards RyR channels, a series of electrophysiology washout experiments were performed to determine the reversibility of Xt3a effects. RyR1 channel recordings were taken before and during exposure to 100 pM, 10 nM and 1 μM Xt3a, then “early” (2 to 3 min) and “late” (15 to 23 min) after washout (Fig. 3a). Notably, no significant washout of Xt3a effect was observed, with activity remaining much higher than the control throughout the washout period. It is also notable that sub-state activity increased during the washout period and was maintained for as long as the bilayer lasted.

**Fig. 3: Electrophysiological response after removal of Xt3a and Xt3a-D1.**

With RyR2 there was no significant change in activity during exposure to the toxin as discussed above. Surprisingly, activity did appear to increase somewhat during washout (Fig. 3). Activity in some RyR2 channels increased shortly after washout and then declined at longer times as seen in the first RyR2 channel (Supplementary Fig. 8) after washout of Xt3a at 10 nM. In other RyR2 channels, e.g., the second RyR2 channel recordings (Supplementary Fig. 8), activity did not change significantly at short times but then increased after longer washout periods following exposure to Xt3a at 1 μM. The increased activity during washout could be attributed to the unmasking of RyR2 activation by removal of a weak inhibitory effect of Xt3a binding to a low affinity site.

Xt3a is a bivalent toxin that enhances Ca²⁺ leak from the sarcoplasmic reticulum

The persistent Xt3a response (high avidity) suggests a bivalent mode of action. We, therefore, produced each domain of Xt3a (sequences as shown in Fig. 1a); Xt3a-D1 and Xt3a-D2, as well as IpTxA recombinantly as SUMO fusions, in the above-described expression system and purified by rpHPLC (Supplementary Figs. 9, 10). Electrophysiology experiments were carried out to determine the potency of each peptide. While both IpTxA and Xt3a-D1 showed potent (pM to nM) activation of RyR1 channels, Xt3a-D2 was inactive at all concentrations tested (Supplementary Fig. 11). It is known that the activity of IpTxA is reversible²⁹, so we next performed washout experiments to determine if the activity of Xt3a-D1 was also reversible. The results show a rapid return to control conditions after less than 1 minute of washout. Taken together these results indicate that the activity of Xt3a is largely due to the first domain (Xt3a-D1) while the presence of the second domain (Xt3a-D2) makes this activity persistent.

To further test the activity in a more native environment, we employed a muscle fiber experiment^37,38,39. Here, the amount of Ca²⁺ leakage out of the sarcoplasmic reticulum (SR) in mouse extensor digitorum longus (EDL) fibers is examined. To do this, we determined the total SR Ca²⁺ content ([Ca_T]_SR) of skinned fibers before and after a 1–min leak protocol (control leak) using a previously established membrane-lysis method, which measures the force response to Ca²⁺ liberated from lysed membrane compartments by a triton-oil emulsion (Fig. 4a, b). Experiments were also carried out with either 10 nM of Xt3a, Xt3a-D1, Xt3a-D2, or IpTxA present in the leak solution, using exactly the same procedures and solutions. It was found that [Ca_T]_SR following the control leak was significantly depleted by 18 ± 7%. Importantly, we found that the presence of 10 nM of any of the four peptides in the leak solution depleted significantly more [Ca_T]_SR (by 76 ± 5%, 58 ± 13%, 36 ± 9%, and 55 ± 18% for Xt3a, Xt3a-D1, Xt3a-D2, and IpTxA, respectively). These results indicate that the SR Ca²⁺ leakage in the presence of the peptides was significantly greater than the control leak alone. The efficiency of the peptides at a concentration of 10 nM to increase the SR Ca²⁺ leakage was in the following order: Xt3a > Xt3a-D1 ~ IpTxA > Xt3a-D2 (Fig. 4d). These results are consistent with the electrophysiology recordings described above.

**Fig. 4: Xt3a potently and bivalently activates ryanodine receptors.**

Evolution of a family of double calcins

To explore the evolutionary origin of Xt3a, we first performed a BLAST search against the venom gland and body transcriptomes of X. tumulensis using the sequences of both the full-length and single domains. These searches returned two distinct forms of putative ICK peptides: double-domain ICK peptides from the peptide family named xibalbin family 3, where each domain contained three disulfides, and single-domain putative ICK peptides from xibalbin family 1 that contain an additional disulfide that presumably stabilises loop four. Of these, only single-domain ICKs were detected in both the venom gland and body transcriptomes, indicating that the double-ICK form is exclusive to the venom. We next searched UniProtKB and the NCBI non-redundant database using BLAST. However, these BLAST searches returned no pancrustacean hits, and we therefore used jackhmmer to search all arthropod sequences contained within UniProtKB. Searching with individual ICK domains from xibalbin family 3 returned 137 pancrustacean hits, of which 53 were ICK and none were multidomain ICK. Searching with the full-length Xt3a returned only six pancrustacean hits, none of which were double-domain ICK sequences. Thus, while double-ICK peptides have previously been detected in spiders, Xt3a and the remaining members of xibalbin family 3 appear to represent a convergent class of such peptides from Pancrustacea.

Aligning the identified ICK domains and reconstructing their phylogenetic relationship by maximum likelihood confirmed that Xt3a and xibalbin family 3 did not evolve from the only single-domain ICKs detected in the transcriptomes, as evidenced by the well-supported monophyletic clades of three- and four-disulfide ICKs (Fig. 5a; Supplementary Fig. 12; Supplementary Data 1 and Supplementary Data 2). Although we were unable to completely resolve the phylogenetic relationships between the domains of xibalbin family 3, our results indicate that they probably evolved through a single domain duplication of a three-disulfide ICK precursor that has since been lost. The lack of resolution is also reflective of the variable rates of evolution between the two domains, with domain 2 containing several rapidly evolving sites (Fig. 5b and Supplementary Table 2). To further explore the domain-specific evolution of the xibalbin family 3 ICK domains, we aligned the individual domains to all functionally annotated ICK toxins in UniProtKB. We then compared the biophysical properties of each ICK domain by performing a PCA on the resulting matrix and projecting each sequence in a three-dimensional sequence space consisting of the first three principal components (Fig. 5c, middle). This approach reinforced the observed convergence between Xt3a-D2 and the calcin scorpion toxin family (Fig. 5c, and Supplementary Table 3): Calcins account for five of the ten physicochemically most similar ICK domains to Xt3a-D2, which is about as similar to the closest calcin (Imperacalcin, P59868) as it is to Xt3a-D1. In contrast, only one calcin is among the ten most similar sequences to Xt3a-D1 (10th most similar, BmCa.1, Q8I6X9). Taken together, these results suggest that xibalbin family 3, represented here by Xt3a, emerged in remipedes through a domain duplication event and then underwent functional diversification through whole-gene duplication and domain-selective evolution.

Discussion

The structural and functional studies presented here reveal the remipede toxin, Xt3a, to be a double-knot toxin in the calcin family and a potent, specific, and avid ryanodine receptor activator. Xt3a is the fourth naturally occurring tandem repeat ICK peptide reported, and the third where the structure and function has been elucidated. While each of these three peptides target a different ion channel (DkTx with TRPV1, Hi1a with ASIC1a and Xt3a with RyR1), each display a bivalent mode-of-action, evident in a remarkable enhancement of avidity associated with their dimeric structures. In Xt3a, we observe persistent activity after washout in our single-channel recordings for as long as the bilayers lasted. In contrast, when only one of the two domains is present we see a loss of this persistent activity, supporting a multivalent binding mode. Analysis of the structure-activity data using isolated domains of Xt3a, suggests that the first domain of the peptide (Xt3a-D1) causes an increase in channel opening while the second domain (Xt3a-D2) is required to make this activity persistent, likely by binding to an adjacent receptor site. Avidity is a sought-after property of pharmaceutical drugs, leading peptide chemists to design dimeric synthetic peptides (homo or hetero-dimeric), to mimic the behavior of these natural toxins^40,41,42. These investigations have had mixed results with either no gain in avidity observed or presence of avidity that cannot be linked to bivalent receptor engagement.

The source of this naturally evolved bivalency is likely a combination of individual domain sequences that target adjacent receptor sites, as well as a linker sequence to spatially orient the two domains in a defined quaternary structure. The latter may further enhance the potency of the bivalent molecule by excluding non-binding orientations or stabilizing orientations that favor bivalent binding^43,44. Thus, the linker sequence is likely to be indirectly related to the structure of the receptor (i.e., not necessarily through direct linker–receptor interactions). Indeed, there appears to be significant variation in the linkers of the double ICK peptides studied to date, leading to distinct inter-domain orientations. In DkTx, the two domains are loosely connected via a long (12-residue) linker, and in the receptor-bound state the domains are oriented in a side-to-side orientation binding to remote but equivalent binding sites in the homo-tetrameric receptor (lateral translation along one axis to superimpose the two domains)¹⁵. In the case of Hi1a (6-residue linker), there is a hydrophobic pocket between the two domains where a linker phenylalanine is inserted, resulting in a back-to-side orientation (a 90° rotation about one axis followed by a 180° rotation along an orthogonal axis to superimpose the two domains)¹². The second binding site of Hi1a on ASIC1a is not known and it is therefore unclear how this orientation leads to the observed gain in avidity. Xt3a has the shortest linker (4-residues), and folds into a back-to-back orientation (two 180° rotations about orthogonal axes for superimposition of domains). The diversity of domain orientations suggests evolution of quaternary structure in multi-domain toxins to enhance receptor avidity is an emerging and unexplored dimension of venom evolution.

The confirmation that a remipede venom contains double ICK toxins is particularly interesting given the similarity of Xt3a to the calcin scorpion toxin family. First, we observe that while the ICK-motif itself is abundant across venomous species, elaboration of this through domain duplication has only been found in spiders previously^12,13. Second, the sequence of the C-terminal domain of Xt3a falls within the calcin family of peptides that are known to target RyRs, a family of peptides that has, to date, only included sequences from scorpions²³. Interestingly, the second domain of Xt3a, which is the most similar to calcins, is by itself only weakly active against RyR1, perhaps because it lacks three of the six residues known to be important in the function of scorpion calcins²⁷ (Supplementary Fig. 13a and b). While the striking structural convergence between Xt3a-D2 and IpTxA could indicate similar binding site, it is not the mechanism responsible for the evolution of xibalbin RyR toxins, as shown by the activity of the structurally divergent Xt3a-D1 (Supplementary Fig. 13b and c). However, given that the full length Xt3a is even more potent than IpTxA, we speculate that these convergent properties enable binding of the second ICK domain of Xt3a to a second receptor site. The modulation of RyR is thus not necessarily achieved by the overlapping structural features of Xt3a and other calcins. Instead, Xt3a achieves its full potency through an evolutionary innovation that has to date only been identified in spider venoms and subsequent convergent evolution with toxins that have to date only been identified from scorpions.

It is not surprising that there are isoform-specific differences in the effects of Xt3a on RyR1 and RyR2. There are sequence and structural differences between the proteins (Supplementary Fig. 14), and many responses can differ between the isoforms, including inactivation by high cytoplasmic Ca²⁺ ^45,46, calmodulin⁴⁷, and IpTxA^29,48,49, while GSTm2 slightly increases the activity of RyR1, but strongly inhibits RyR2⁵⁰. The difference could simply indicate that the Xt3a binding site is in the vicinity of a sequence difference that alters the structure of the binding site; or that the sequence difference alters the intramolecular pathway between the binding site and the channel gating residues, in a manner similar to disease associated mutations in the RyR1 and RyR2^51,52.

The data presented here clearly demonstrate that application of Xt3a leads to release of calcium stores via RyR activation, however, details of the underlying mechanism remain to be elucidated. Further biochemical, biophysical, structural and functional studies are required to determine how this is achieved. Structural details of the receptor bound form of Xt3a will be particularly valuable as it will provide a rationale for the observed domain orientation and the role of the individual domains of the peptide.

Together, our findings present a remarkable example of convergent evolution across levels of molecular structure to disrupt an excitation contraction coupling mechanism for immobilizing prey that is rarely targeted by animal venoms. However, they also point to the emergence of quaternary structure in multidomain venom peptides as a general evolutionary innovation for achieving unique pharmacological properties that enable new ecological functions. Studies of these natural products will be important in rational engineering of their synthetic counterparts as therapeutic and agrochemical leads.

Methods

Recombinant peptide production

Recombinant expression of Xt3a, Xt3a-D1, Xt3a-D2 and IpTxA was performed using an E. coli expression system. A gene encoding the peptide was subcloned into an expression vector containing a coding region with poly-histidine purification tag as well as a solubility tag (MBP for Xt3a and SUMO for Xt3a-D1, Xt3a-D2 and IpTxA) with a tobacco etch virus (TEV) protease cleavage site located between the solubility tag and target peptide. The expression vector was transformed into the genetically engineered SHuffle cells which support the correct formation of disulfide bonds^28,53. E. coli SHuffle cells supplemented with ampicillin were grown at 30 °C until OD₆₀₀ = 0.8–1.2, then induced with 0.1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and incubated overnight at 16 °C. Purification was performed using immobilized metal affinity chromatography (IMAC) and reversed-phase HPLC standard techniques as described previously^28,36. For IMAC purification, cells were resuspended in buffer (250 mM NaCl, 25 mM Tris, pH 7.8) and lysed using sonication, the soluble cell lysate was applied to a buffer equilibrated 5 mL Ni-NTA column (Qiagen), and the fusion proteins were eluted using 250 mM imidazole. Prior to reversed-phase HPLC, cleavage using TEV protease was performed for each fusion protein. Xt3a, Xt3a-D1 and Xt3a-D2 were cleaved in a TEV/fusion-protein ratio of 1:10 in buffer containing (150 mM NaCl, 20 mM Tris, 2.5 mM GSH, 0.25 mM GSSG, pH 7.8). IpTxA was cleaved using both SUMO and TEV protease using a SUMO/TEV/fusion-protein ratio of 1:10:300 in buffer containing (150 mM NaCl, 20 mM Tris, 5 mM GSH, 0.5 mM GSSG, 0.5 M urea, pH 7.8). The cleaved peptides were then purified using a C-18 reversed-phase HPLC column. Folding of Xt3a-D1 and Xt3a-D2 was confirmed by comparison with the 1D NMR spectra of Xt3a and IpTxA was confirmed by comparison to published NMR TOCSY spectra²⁷.

Mass spectrometry

Mass analysis of target peptides was performed using matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry. The matrix was prepared using a saturated stock solution of α-Cyano-4-hydroxycinnamic acid (CHCA) in acetone, mixed with (ethanol:acetone: 0.1% trifluoroacetic acid (TFA) (6:3:1)) at a 1:9 ratio. Sample preparation was done by combining the matrix solution and the HPLC purified peptide (1:2) and adding 1.5 µL of sample to a ground steel target plate. All data was collected using linear mode on a MALDI-TOF mass spectrometer (Bruker Daltonix Autoflex Speed).

SR isolation and single RyR channel experiments

Cardiac SR was prepared from mature female crossbred sheep hearts⁴⁶, and skeletal SR vesicles were isolated from the back and leg muscles of mature female New Zealand white rabbits^29,54 with approval from the ANU Animal Experiment Ethics Committee Protocol Number A2015/35. Xt3a, Xt3A-D1, Xt3A-D2, and IpTxA were tested on RyR1 and RyR2 channels inserted into lipid bilayers. Solutions for vesicle incorporation contained (mM): cis 230 caesium methanesulfonate (CsMS); 20 CsCl; 1 CaCl₂ and 10 tetraethylsulfamide (TES) pH 7.4 and trans 30 CsMS; 20 CsCl; 1 CaCl₂ 10 TES; pH 7.4. SR vesicles routinely incorporated with the cytoplasmic surface of the SR and RyR facing the cis chamber. Following incorporation, 200 mM CsMS was added to the trans solution and the cis solution exchanged with recording solution containing (mM): 230 CsMS; 20 CsCl; 0.001 CaCl₂;10 TES and pH 7.4, with [Ca²⁺] set by a [BAPTA] determined using a Ca²⁺ electrode. The cytoplasmic and luminal solutions contained 1 μM and 1 mM Ca²⁺ respectively, with symmetrical 250/250 mM CsMS. Bilayer voltage was switched between +40 mV and −40 mV (cytoplasmic voltage relative to grounded luminal solution) every 30 s. The activity of the RyR channels used here included 1 µM Ca²⁺ in the cytoplasmic solution and 1 mM Ca²⁺ in the luminal solution^29,55. Electrophysiology experiments were analysed using Channel 2 (P.W. Gage, M. Smith, Australian National University) and Channel 3 (N.W. Laver, University of Newcastle, Australia) software, available from the authors upon request. Statistical analyses were performed using Microsoft Excel (Office 365). The channels have a maximum current of ~10 pA and an average open probability of 0.04 ± 0.01 (RyR1) and 0.009 ± 0.003 (RyR2) before exposure to Xt3a. Following most incorporation events, a single channel only was active in the bilayer and channel open probability (P_o), mean open time (T_o), mean closed time (T_c) and open event frequency (F_o) were measured. When 2–4 channels were active in a bilayer, P_O was approximated from the fractional mean current (I’F), i.e., mean current divided by maximum current. I’F is equal to P_O in a single channel and indicates the average P_O of multiple channels in a bilayer⁵⁶. The experiments exploring the detailed actions of Xt3a on RyR1 and RyR2 were collected and analysed at +40 mV and at −40 mV (at the Australian National University – ANU). Experiments exploring the actions of Xt3a-D1, Xt3a-D2 and IpTxA on RyR1 were collected only at +40 mV (at the University of Newcastle – UN). Experiments at UN also included a minority of multi-channel experiments. The bilayer rigs, solution composition, source of channels, data acquisition and analyses methods were all identical. Parameters measured at +40 mV and at −40 mV showed similar effects of Xt3a, therefore data from both potentials were combined in the average parameter values reported under each condition. In all experiments control channel activity was recorded for 3 to 5 min before exposure to the test compound. To fully explore the actions of Xt3a, each channel was exposed to only two concentrations of Xt3a before washout in order to detect the full effect of each concentration over time periods of 5 to 10 min. Therefore, separate data sets for RyR1 were obtained for: 10 and 100 pM; 1 and 10 nM; and 0.1 and 1 µM Xt3a. Separate data sets for RyR2 were obtained for: 1 and 10 nM; and 0.1 and 1 µM Xt3a. Detailed Xt3a washout experiments were performed by perfusion of the bilayer bath with a recording solution lacking Xt3a after which RyR activity was recorded for 15 to 30 min. In experiments to assess relative activity and avidity of Xt3a-D1, Xt3a-D2, IpTxA and Xt3a (at UN), channels were exposed to each peptide for 1 to 5 min (5 min for Xt3a) followed by washout for 3–25 min (3 min for Xt3a-D1, 25 min for Xt3a) before repeating by adding the same or a different compound.

Cell based fluorescence imaging plate reader (FLIPR) Ca²⁺ assays

SH-SY5Y human neuroblastoma cells (European Collection of Authenticated Cell Culture, Sigma Aldrich, 94030304-1VL) were cultured in RPMI media (ThermoFisher Scientific, Scoresby, Australia) supplemented with 15% foetal bovine serum and L-glutamine (1 mM) and passaged at approximately 80% confluency with TrypLE Express (Thermo Fisher, Australia). For fluorescence imaging, cells were plated on CellBIND (Corning) 384-well black-walled imaging plates at a density of 20,000–30,000 cells/well in complete media and cultured for 48 h at 37 °C/5% CO₂.

The effects of Xt3a (3 µM) on endogenously expressed α7 nAChR, α3β2/α3β4 nAChR (referred to as α3-containing; α3 nAChR), Ca_V1.3, Ca_V2.2, Na_V1.2 and Na_V1.7 channels were assessed by fluorescence Ca²⁺ imaging in SH-SY5Y cells as previously described^33,34. Briefly, SH-SY5Y cells were loaded with Calcium 4 no-wash dye (Molecular Devices) diluted in physiological salt solution (composition in mM: NaCl 140, D-glucose 11.5, KCl 5.9, MgCl₂ 1.4, NaH₂PO₄ 1.2, NaHCO₃ 5, CaCl₂ 1.8, HEPES 10) for 30 min at 37 °C. A two-addition FLIPR^Tetra (Molecular Devices) protocol using the following settings was used to measure fluorescence responses: excitation 470–495 nm; emission 515–575 nm; excitation intensity 80%; excitation duration 0.8 s; gain 140; read interval 1/s; read number 300/addition. Responses mediated via endogenously expressed ion channels were elicited by addition of: choline (30 μM)/PNU-120596 (10 μM) for α7 nAChR-mediated responses; nicotine (30 μM) for α3β2/α3β4 nAChR-mediated responses; KCl (90 mM)/CaCl₂ (5 mM) for Ca_V1.3-mediated responses; KCl (90 mM)/CaCl₂ (5 mM) + nifedipine (10 μM) for Ca_V2.2-mediated responses; vertridine (70 μM) for Na_V1.2-mediated responses; and veratridine (4 μM)/OD1 (300 nM) for Na_V1.7-mediated responses. Raw fluorescence readings were converted to response over baseline using the analysis tool Screenworks 3.1.1.4 (Molecular Devices) and were expressed relative to the maximum increase in fluorescence of control responses and plotted using GraphPad Prism 9.3.1.

Fiber mounting and force recording

All experiments were approved by The University of Queensland Animal Ethics Committees. Male and female C57/Bl6 2–6-month-old mice were sacrificed by asphyxiation via CO₂ exposure and the EDL muscles were rapidly excised. The EDL was pinned at resting length in a petri dish lined with Sylgard 184 (Dow Corning, Midland, MI) and immersed in paraffin oil (Ajax Chemicals, Sydney, Australia). Segments of individual fibers were mechanically skinned using jeweler’s forceps and pinned out unstretched under oil^37,38,39. The skinned fiber was then mounted at 120% of resting length on a force transducer (Myotronic UG, Heidelberg, Germany) before transfer to a 2-ml Perspex bath containing standard K⁺-based solution that broadly mimics the intracellular milieu. The standard solution for skinned fibers contained (in mM): hexa-methylene-diamine tetraacetate (HDTA²⁻), 50 (Fluka, Buchs, Switzerland); total ATP, 8; Na⁺, 36; K⁺, 126; total Mg²⁺, 8.5 (giving 1 mM free [Mg²⁺]); creatine phosphate, 10; total EGTA, 0.05; Hepes, 90; pH 7.1 and pCa (-log10[Ca²⁺]) ~7.1, except where stated. All chemicals were purchased from Sigma-Aldrich (St Louis, MO, USA) unless specified otherwise.

Variations of the standard solution were prepared. To deplete the caffeine releasable Ca²⁺ (“full release solution”), 30 mM caffeine was added, [Mg²⁺] was lowered to 0.05 mM (total Mg²⁺ of 2.1 mM) and free EGTA was adjusted to 0.5 mM (pCa 8.5) to chelate released Ca²⁺. To measure the maximum force produced by the skinned fiber, all HDTA was replaced by EGTA (relaxing solution) or CaEGTA (maximum Ca²⁺ activating solution). The relaxing solution contained 50 mM EGTA and no added Ca²⁺ (pCa > 9) and the maximum Ca²⁺-activating solution contained 49.5 mM Ca²⁺ (pCa 4.7), with total Mg²⁺ of 10.3 and 8.1 mM, respectively, to maintain the free [Mg²⁺] at 1 mM. A “leak solution” was also prepared, where [Mg²⁺] set at 0.1 mM (total Mg²⁺ of 3.4 mM) to increase the P_O of RyR and with 2 mM EGTA (pCa ~8.5) to chelate leaky Ca²⁺ from the SR. In addition, 10 nM of either Xt3a, Xt3a-D1, Xt3a-D2 or IpTxA, were added from their respective stock solution to the control leak solution to determine the individual effect of these peptides on the SR Ca²⁺ leakage. The BAPTA solution used to pre-equilibrate fibers before lysing was similar to the standard K-HDTA solution but EGTA was replaced with 0.1–1.6 mM BAPTA^37,39.

Quantifying total Ca²⁺ content in the fiber

Briefly, the skinned fiber was first placed in the standard weakly Ca²⁺-buffered K-HDTA solution for 2 min which does not alter the endogenous Ca²⁺ content of the fiber. The skinned fiber was then equilibrated for 20 s in a solution with a set [BAPTA] before being placed in a freshly triturated emulsion of Triton X-100 in paraffin oil (TX–oil) (10% v/v). The Ca²⁺ released upon the membrane lysing rapidly binds to the known amount of BAPTA present within the fiber and to other sites, predominantly troponin C (TnC). The pre-equilibrating [BAPTA] was chosen such that the fiber produced a finite, non-maximal force response upon lysis. Pre-treatment of the fiber with “full release solution” allowed the non-SR Ca²⁺ content of the skinned fiber to be assayed. The total amount of Ca²⁺ present in the fiber could be calculated from the [BAPTA] in the equilibration solution and the magnitude of the force response. Data are presented as mean ± SD, with n denoting the number of fibers examined. Statistical significance (p < 0.05) was determined with One-way ANOVA.

Structure determination

The structure of Xt3a was determined using heteronuclear NMR. The sample contained 500 µM of ¹³C/¹⁵N-labeled Xt3a in 20 mM sodium phosphate pH 8, 10 µM DSS, 5% D₂O, 1 mM EDTA and 0.02% NaN₃. All spectra were recorded at 25 °C on a Bruker 900 MHz spectrometer equipped with a triple resonance cryogenically cooled probe (Bruker, Billerica, MA). Resonance assignments were obtained from two-dimensional (2D) ¹H-¹⁵N-HSQC, 2D ¹H-¹³C-HSQC, 3D HNCACB, 3D CBCA(CO)NH, 3D HNCO, and 3D HBHA(CO)NH, 3D H(CCCO)NH, 3D (H)C(CCO)NH and 3D HCCH-TOCSY (BMRB ID: 30944). The 3D spectra were acquired using nonuniform sampling and processed using maximum entropy reconstruction with the Rowland NMR Toolkit as described previously⁵⁷. The interproton distance restraints used for structure calculations were derived from 3D ¹H-¹³C-aliphatic, ¹H-¹³C-aromatic, and ¹H-¹⁵N NOESY spectra acquired using uniform sampling with a mixing time of 150 ms. The spectra were analysed using CcpNmr v2.4.1⁵⁸. Dihedral-angle restraints were derived from TALOS-N chemical shift analysis program⁵⁹, with the restraint range set to twice the estimated standard deviations. The NOESY spectra were manually peak-picked and the torsion angle dynamic package CYANA v3.98.13⁶⁰ was then employed to automatically assign the peaks, extract distance restraints and calculate an ensemble of structures. The disulfide-bond connectivity was determined from preliminary structure calculations performed without any disulfide-bond restraints⁶¹. The inter-cystine NOEs in the NOESY spectra are consistent with the pattern Cys14-Cys29, Cys21-Cys34, Cys28-Cys45, Cys50-Cys65, Cys57-Cys70 and Cys64-Cys80. CYANA calculated 200 structures from random starting conformations and the best 10 conformers were selected, based on their final CYANA target function value, to represent the structure of Xt3a. Coordinates for the Xt3a ensemble are available from the Protein Data Bank (PDB ID: 7RZ3).

Production and circularisation of membrane scaffold protein MSP9

The method for producing circularised MSP9 (cNW9) was as described in Nasr et al.⁶². In brief, the MSP9 gene containing a sortase A (SrtA) recognition sequence (LPGT) in the C-terminal was cloned into pET29a vector and the protein was produced recombinantly in E. coli BL21 (DE3). After purification using IMAC, the MSP9 was circularised using SrtA in reaction buffer containing 25 mM Tris·HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 2 mM DDM and 1 mM 2-mercaptoethanol (BME). The molar equivalent ratio of MSP9:SrtA in the reaction was 1:1 and the reaction was initiated by the addition of 10 mM CaCl₂. The reaction was carried out at 37 °C for 16 h.

Following the completion of circularisation, the sample was purified by reverse-IMAC to remove any unreacted material and SrtA. In this step, the Ni-NTA resin was pre-equilibrated with buffer containing 25 mM Tris·HCl pH 7.5, 150 mM NaCl and the flow-through containing cNW9 was collected. The flow-through fraction was then desalted into equilibration buffer (25 mM Tris·HCl pH 7.5, 1 mM DDM) and it was applied onto a 5 mL HiScreen Q HP (GE Healthcare) anion-exchange column at 4 °C using an ÄKTA FPLC system (GE Healthcare). At a flow rate of 0.3 mL/min, a linear gradient from 0 to 30% of equilibration buffer supplemented with 1 M NaCl over 20 column-volumes (CVs) was then applied to elute the pure cNW9. The purity of the fractions was assessed by SDS-PAGE and fractions containing cNW9 with >95% purity were pooled for nanodisc (ND) assembly.

POPC-cNW9 nanodisc assembly

The method of circularised ND (cND) assembly was developed based on previous reports^62,63. A stock solution containing 20 mg of POPC in chloroform was dried down under nitrogen gas in a glass tube and the lipid film was left under vacuum overnight. The dried film was rehydrated with reconstitution buffer (20 mM Tris·HCl pH 7.4, 100 mM NaCl, 0.5 mM EDTA and 200 mM cholate) to make POPC stock at 100 mM. The solution was sonicated for 10 mins in a warm water bath at 60 °C to fully reconstitute the lipids in the buffer. To assemble the cND, cNW9 solution and POPC/cholate stock were mixed at a cNW9:POPC:cholate molar ratio of 1:43:86. The mixture was incubated for 1 h on ice with gentle rocking and the assembly was initiated by the addition of 0.5–1 g of Bio-Beads SM-2 (Bio-rad) to every mL of reaction volume. The mixture was kept on ice with rocking for another 3 hours for the Bio-Beads to remove the detergent in the sample. The solution was filtered through a 0.45 μm PES membrane to remove the Bio-Beads and then directly injected onto a Superdex 200 increase 10/300 column (GE Healthcare) equilibrated with 20 mM Tris·HCl pH 7.4, 100 mM NaCl and 0.5 mM EDTA using a ÄKTA FPLC system (GE Healthcare). Fractions containing POPC-cNW9 ND were pooled and the homogeneity and size distribution of the cND sample was assessed using negative-stain EM.

Negative Stain TEM

400-mesh carbon-coated (5–6 nm thick) copper grids (ProSciTech Pty Ltd, Kirwan, Australia) were glow-discharged for 15 s before the protein was applied. 4 µL of POPC-cNW9 ND at 20 nM (20 mM Tris·HCl pH 7.4, 100 mM NaCl and 0.5 mM EDTA) was pipetted onto the grid and allowed to settle for 1 min. This was followed by one wash step in a drop of water and the grid was immediately moved to a fresh drop of 1% uranyl acetate to stain for 1 min. TEM was carried out on a Hitachi HT7700 electron microscope at 80 kV.

NMR titrations of POPC-cNW9 nanodiscs to Xt3a

¹H-¹⁵N-HSQC spectra of Xt3a with and without the presence of ND were recorded on a 900 MHz spectrometer equipped with a cryogenically cooled triple resonance probe (Bruker, Billerica, MA) at 25 °C. Each sample contained 50 μM of ¹⁵N/¹³C-labelled Xt3a in 20 mM sodium phosphate pH 8.0, 10 µM DSS, 5% D₂O, and 1 mM EDTA, either with no or 100 μM POPC-cNW9 ND. Spectra were processed and analysed using Topspin (v4.1.3, Bruker).

Relaxation experiments

¹⁵N spin-lattice (R₁), transverse (R₂) relaxation, and ¹H-¹⁵N NOE experiments for Xt3a were recorded at 25 °C on a 900 MHz spectrometer equipped with cryogenic probe (Bruker, Billerica, MA). The sample contained 500 μM of ¹⁵N/¹³C labeled Xt3a (as above). The relaxation delay was sampled at 10, 20, 60, 100, 200, 400, 600 and 1200 ms for the R₁ experiments and 16, 33, 67, 135, 169, 203, 237 and 271 ms for the R₂ measurements. Spectra were processed using Topspin (v4.1.3, Bruker) and the signal decay was analysed and plotted using CcpNmr (v2.4.1). The time constant error (TC in CcpNmr) from the exponential fit is used in the the R₁ and the R₂ plots. The noise in the spectrum (relative to the peak height) was used to estimate the uncertainty (error bars) in the heteronuclear NOE plots.

Evolutionary analyses

To explore the evolutionary origin of Xt3a, we used blastp (blast+ v.2.10.1 + )⁶⁴ to search both the full-length and single domains against a database of all 228,896 mRNA sequences listed under Remipedia in NCBI and translated to all potential open reading frames encoding 40 amino acids or more (880,562 sequences). We also searched the trinity-assembled venom gland and whole-body transcriptomes reported by von Reumont et al.¹⁷, the arthropod component of a custom database containing trinity-assembled transcriptomic datasets from 125 species of arthropods obtained from the NCBI SRA reported previously^65,66, as well as the NCBI nr and UniProtKB databases. We used standard blastp settings and retained all sequence hits containing at least one putative ICK domain, identified as containing either of the canonical cysteine patterns corresponding to either of the three- or four-disulfide ICK forms (3-DS and 4-DS, respectively). Given that we did not identify any single-domain 4-DS among the remipede sequences using blastp, we also queried the remipede databases with jackhmmer (HMMER v3.1b2⁶⁷) to iteratively search all remipedes 3-DS and 4-DS ICKs against the same protein databases, using an inclusion threshold score of 30 and once again manually filtering out non-ICK sequences.

The identified sequences were combined to a single fasta file and clustered sequences with a similarity greater than 99% using CD-HIT v4.6.5⁶⁸. Of the pancrustacean single-domain ICKs, GSCOCT00013103001.2-RA-CDS_S6D9L2 from Cotesia congregata was removed due to very long inter-cysteine loops and because its insect clade (Hymenoptera) is relatively well represented, X1X2U9 from Acyrthosiphon pisum was removed due to an unusual propeptide or very long N-terminus which could be due to frameshift, while the remipedes sequence JL112461.1 and A0A0B4UDE1 from Drosophila mojavensis were removed due to missing cysteines. We then split each sequence containing multiple ICK domains into separate sequences for each domain and aligned all ICK domains using the local paired iterative alignment method (L-INS-i) in MAFFT v7.304b64⁶⁹. We then realigned the structurally important conserved cysteines⁵, and used the MAFFT regional alignment ruby script to align the pre-, inter-, and post-cysteine regions by local paired iterative alignment as above. We selected the most appropriate evolutionary model (VT + I + G4) using ModelFinder⁷⁰, before we used IQ-TREE v1.5.5⁷¹ to reconstruct the molecular phylogeny of our ICK domains by maximum likelihood, estimating branch support values by ultrafast bootstrap using 10,000 replicates⁷². Trees were visualised in Archaeopteryx v0.9921⁷³. We also used IQ-TREE to estimate the site-specific substitution rates by maximum likelihood of the remipede double-ICK peptides, which were aligned using MAFFT as above.

To examine the convergent evolution of Xt3a and toxins belonging to the calcin family, we downloaded all functionally annotated ICK venom peptides from UniProtKB, trimmed them to contain only mature peptide domains, removed identical sequences using CD-HIT, and aligned these and the individual domains of all remipede ICK peptides using the regional alignment approach described above. We then clustered and projected the biophysical properties of each sequence in a multidimensional sequence space as described previously^66,74, using [R] codes obtained from https://github.com/TS404/SeqSpace. Briefly, the alignment was converted into a numerical matrix and analyzed using principal component analysis in R to summarize the main covarying sets of properties. The variables used were molecular weight (Da), net charge (Coulombs), hydrophobicity (Doolittle index), disorder propensity (TOP-IDP), disulfide potential (binary descriptor) and occupancy (binary descriptor).

Statistical analysis

In the cell-based FLIPR assays statistical analysis was performed using GraphPad Prism 9.3.1. Statistical significance was defined as p < 0.05, and determined by one-sample t-test assessing difference to the control value of 100%. In α7 nAChR, α3-containing nAChR, Ca_V1.3, Ca_V2.2, Na_V1.2 and Na_V1.7 channels (Supplementary Fig. 5B), with distribution (t) and degrees of freedom (df) being: t = 0.9683, df = 2 (α7); t = 1.338, df = 2 (α3); t = 1.775, df = 2 (Na_V1.2); t = 1.478

Due to the well-recognized range of values between individual RyR channels, in the electrophysiology experiment, all parameters (P_o, T_o, T_c and F_o) for each channel are expressed relative to the internal control values for that channel, measured prior to application of Xt3a. Occasional measurements were excluded from data sets when with P_O values were 10 to 30 times outside the range of other channels in the same experiment. This included 1 of 16 measurements in 8 RyR1 channels exposed to 10 to 100 pM Xt3a; 1 of 16 measurements in 8 RyR1 channels exposed 1 nM and 10 nM Xt3a; 4 of 16 measurements from 8 RyR2 channels exposed to 1 and 10 nM Xt3a, and 3 of 18 measurements from 9 RyR2 channels exposed to 0.1 and 1 μM Xt3a. Statistical analysis of single channel data was performed using Excel spreadsheets and embedded Students t-test functions or a sign test as indicated in the graphs in Figs. 1 and 3. For the t-test, a 2-tailed paired t-test was used for the data sets (n = 6 to 10 channels) shown in Fig. 1b and c and for the subset of RyR2 channels maintained through Xt3a washout shown in Fig. 3b (n = 5). A 1-tailed paired t-test was used with the subset of RyR1 maintained through Xt3a washout shown in Fig. 3a (n = 4), as significant increases in activity had been demonstrated in the larger data set shown in Fig. 1.

Reporting summary

Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.

Data availability

The data that support this study are available from the corresponding authors upon reasonable request. Coordinates have been deposited in the Protein Data Bank (PDB) under accession code 7RZ3 (Xt3a) and related NMR data deposited in the Biological Magnetic Resonance Data Bank under accession code 30944 (The solution structure of remipede double-ICK toxin phi-Xibalbin3-Xt3a). Source Data underlying figures are included as a Source Data file. Source data are provided with this paper.

Code availability

Processing scripts and code available from the authors upon request.

References

Newman, D. J. & Cragg, G. M. Natural Products as Sources of New Drugs from 1981 to 2014. J. Nat. Prod. 79, 629–661 (2016).
Article CAS PubMed Google Scholar
Fry BG, et al. Seeing the woods for the trees: understanding venom evolution as a guide for biodiscovery. In: Venoms to Drugs: Venom as a Source for the Development of Human Therapeutics (ed King GF). Royal Soc Chemistry (2015).
Catterall, W. A. et al. Voltage-gated ion channels and gating modifier toxins. Toxicon 49, 124–141 (2007).
Article CAS PubMed Google Scholar
Lavergne V, Alewood PF, Mobli M, King GF. The Structural universe of disulfide-rich venom peptides. In: Venoms to Drugs: Venom as a Source for the Development of Human Therapeutics (ed King GF) (2015).
Undheim, E. A. B., Mobli, M. & King, G. F. Toxin structures as evolutionary tools: using conserved 3D folds to study the evolution of rapidly evolving peptides. Bioessays 38, 539–548 (2016).
Article CAS PubMed Google Scholar
Fry, B. G. et al. The toxicogenomic multiverse: convergent recruitment of proteins into animal venoms. Annu Rev. Genom. Hum. Genet. 10, 483–511 (2009).
Article CAS Google Scholar
King, G. F. Venoms as a platform for human drugs: translating toxins into therapeutics. Expert Opin. Biol. Ther. 11, 1469–1484 (2011).
Article CAS PubMed Google Scholar
Kullmann, D. M. The neuronal channelopathies. Brain 125, 1177–1195 (2002).
Article PubMed Google Scholar
Mobli M, Undheim EAB, Rash LD. Chapter Seven - Modulation of Ion Channels by Cysteine-Rich Peptides: From Sequence to Structure. In: Advances in Pharmacology (eds Geraghty DP, Rash LD). Academic Press (2017).
Pineda, S. S. et al. Structural venomics reveals evolution of a complex venom by duplication and diversification of an ancient peptide-encoding gene. Proc. Natl Acad. Sci. USA. 117, 11399–11408 (2020).
Article ADS CAS PubMed PubMed Central Google Scholar
Maxwell, M., Undheim, E. A. B. & Mobli, M. Secreted cysteine-rich repeat proteins “SCREPs”: a novel multi-domain architecture. Front Pharm. 9, 1333 (2018).
Article CAS Google Scholar
Chassagnon, I. R. et al. Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a. Proc. Natl Acad. Sci. USA. 114, 3750–3755 (2017).
Article ADS CAS PubMed PubMed Central Google Scholar
Bohlen, C. J. et al. A bivalent tarantula toxin activates the capsaicin receptor, TRPV1, by targeting the outer pore domain. Cell 141, 834–845 (2010).
Article CAS PubMed PubMed Central Google Scholar
Vassilevski, A. A. et al. Novel class of spider toxin: active principle from the yellow sac spider cheiracanthium punctorium venom is a unique two-domain polypeptide. J. Biol. Chem. 285, 32293–32302 (2010).
Article CAS PubMed PubMed Central Google Scholar
Cao, E., Liao, M., Cheng, Y. & Julius, D. TRPV1 structures in distinct conformations reveal activation mechanisms. Nature 504, 113–118 (2013).
Article ADS CAS PubMed PubMed Central Google Scholar
Yager, J. Remipedia, A New Class of Crustacea From a Marine Cave in the Bahamas. J. Crust Biol. 1, 328–333 (1981).
Article Google Scholar
von Reumont, B. M., Undheim, E. A. B., Jauss, R. T. & Jenner, R. A. Venomics of remipede crustaceans reveals novel peptide diversity and illuminates the venom’s biological role. Toxins (Basel) 9, 234 (2017).
Article Google Scholar
Apweiler, R. et al. UniProt: the universal protein knowledgebase. Nucleic Acids Res 32, D115–D119 (2004).
Article CAS PubMed PubMed Central Google Scholar
Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403–410 (1990).
Article CAS PubMed Google Scholar
Liu, J. et al. ScrepYard: an online resource for disulfide-stabilised tandem repeat peptides. Protein Sci. 32, e4566 (2023).
Article CAS PubMed PubMed Central Google Scholar
Jungo, F. & Bairoch, A. Tox-Prot, the toxin protein annotation program of the Swiss-Prot protein knowledgebase. Toxicon 45, 293–301 (2005).
Article CAS PubMed Google Scholar
Jungo, F., Bougueleret, L., Xenarios, I. & Poux, S. The UniProtKB/Swiss-Prot Tox-Prot program: a central hub of integrated venom protein data. Toxicon 60, 551–557 (2012).
Article CAS PubMed PubMed Central Google Scholar
Xiao, L. et al. Structure-function relationships of peptides forming the calcin family of ryanodine receptor ligands. J. Gen. Physiol. 147, 375–394 (2016).
Article CAS PubMed PubMed Central Google Scholar
Van Petegem, F. Ryanodine receptors: structure and function. J. Biol. Chem. 287, 31624–31632 (2012).
Article PubMed PubMed Central Google Scholar
Hidalgo, C., Donoso, P. & Carrasco, M. A. The ryanodine receptors Ca2+ release channels: cellular redox sensors? IUBMB Life 57, 315–322 (2005).
Article CAS PubMed Google Scholar
Esteve, E. et al. Critical amino acid residues determine the binding affinity and the Ca2+ release efficacy of maurocalcine in skeletal muscle cells. J. Biol. Chem. 278, 37822–37831 (2003).
Article CAS PubMed Google Scholar
Lee, C. W. et al. Molecular basis of the high-affinity activation of type 1 ryanodine receptors by imperatoxin A. Biochem J. 377, 385–394 (2004).
Article CAS PubMed PubMed Central Google Scholar
Klint, J. K. et al. Production of recombinant disulfide-rich venom peptides for structural and functional analysis via expression in the periplasm of E. coli. PLoS One 8, e63865 (2013).
Article ADS CAS PubMed PubMed Central Google Scholar
Dulhunty, A. F., Curtis, S. M., Watson, S., Cengia, L. & Casarotto, M. G. Multiple actions of imperatoxin A on ryanodine receptors: interactions with the II-III loop “A” fragment. J. Biol. Chem. 279, 11853–11862 (2004).
Article CAS PubMed Google Scholar
Porta, M., Diaz-Sylvester, P. L., Nani, A., Ramos-Franco, J. & Copello, J. A. Ryanoids and imperatoxin affect the modulation of cardiac ryanodine receptors by dihydropyridine receptor Peptide A. Biochim Biophys. Acta 1778, 2469–2479 (2008).
Article CAS PubMed PubMed Central Google Scholar
Sousa, S. R., Vetter, I., Ragnarsson, L. & Lewis, R. J. Expression and pharmacology of endogenous Cav channels in SH-SY5Y human neuroblastoma cells. PLoS One 8, e59293 (2013).
Article ADS CAS PubMed PubMed Central Google Scholar
Yin K, Baillie GJ, Vetter I. Neuronal cell lines as model dorsal root ganglion neurons: A transcriptomic comparison. Mol Pain 12, (2016).
Vetter, I. et al. Characterisation of Na(v) types endogenously expressed in human SH-SY5Y neuroblastoma cells. Biochem Pharm. 83, 1562–1571 (2012).
Article CAS PubMed Google Scholar
Vetter, I. & Lewis, R. J. Characterization of endogenous calcium responses in neuronal cell lines. Biochem Pharm. 79, 908–920 (2010).
Article CAS PubMed Google Scholar
Sharma, G. et al. Recombinant production, bioconjugation and membrane binding studies ofPn3a, a selective NaV1.7 inhibitor. Biochem Pharm. 181, 114148 (2020).
Article CAS PubMed Google Scholar
Zhang, A. H. et al. Elucidating the lipid binding properties of membrane-active peptides using cyclised nanodiscs. Front Chem. 7, 238 (2019).
Article ADS CAS PubMed PubMed Central Google Scholar
Lamboley, C. R., Murphy, R. M., McKenna, M. J. & Lamb, G. D. Endogenous and maximal sarcoplasmic reticulum calcium content and calsequestrin expression in type I and type II human skeletal muscle fibres. J. Physiol. 591, 6053–6068 (2013).
Article CAS PubMed PubMed Central Google Scholar
Fryer, M. W. & Stephenson, D. G. Total and sarcoplasmic reticulum calcium contents of skinned fibres from rat skeletal muscle. J. Physiol. 493(Pt 2), 357–370 (1996).
Article CAS PubMed PubMed Central Google Scholar
Lamboley, C. R. et al. Contractile properties and sarcoplasmic reticulum calcium content in type I and type II skeletal muscle fibres in active aged humans. J. Physiol. 593, 2499–2514 (2015).
Article CAS PubMed PubMed Central Google Scholar
Peschel, A. et al. Two for the price of one: heterobivalent ligand design targeting two binding sites on voltage-gated sodium channels slows ligand dissociation and enhances potency. J. Med Chem. 63, 12773–12785 (2020).
Article CAS PubMed PubMed Central Google Scholar
Tran, H. N. T. et al. Enzymatic ligation of a pore blocker toxin and a gating modifier toxin: creating double-knotted peptides with improved sodium channel NaV1.7 inhibition. Bioconjug Chem. 31, 64–73 (2020).
Article CAS PubMed Google Scholar
Murray, J. K. et al. Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1. Bioorg. Med Chem. Lett. 25, 4866–4871 (2015).
Article CAS PubMed Google Scholar
Mack, E. T. et al. Dependence of avidity on linker length for a bivalent ligand-bivalent receptor model system. J. Am. Chem. Soc. 134, 333–345 (2012).
Article CAS PubMed Google Scholar
Kitov, P. I. & Bundle, D. R. On the nature of the multivalency effect: a thermodynamic model. J. Am. Chem. Soc. 125, 16271–16284 (2003).
Article CAS PubMed Google Scholar
Chu, A., Fill, M., Stefani, E. & Entman, M. L. Cytoplasmic Ca2+ does not inhibit the cardiac muscle sarcoplasmic reticulum ryanodine receptor Ca2+ channel, although Ca(2+)-induced Ca2+ inactivation of Ca2+ release is observed in native vesicles. J. Membr. Biol. 135, 49–59 (1993).
Article CAS PubMed Google Scholar
Laver, D. R. et al. Cytoplasmic Ca2+ inhibits the ryanodine receptor from cardiac muscle. J. Membr. Biol. 147, 7–22 (1995).
Article CAS PubMed Google Scholar
Yamaguchi, N., Xu, L., Pasek, D. A., Evans, K. E. & Meissner, G. Molecular basis of calmodulin binding to cardiac muscle Ca(2+) release channel (ryanodine receptor). J. Biol. Chem. 278, 23480–23486 (2003).
Article CAS PubMed Google Scholar
Tripathy, A., Resch, W., Xu, L., Valdivia, H. H. & Meissner, G. Imperatoxin A induces subconductance states in Ca2+ release channels (ryanodine receptors) of cardiac and skeletal muscle. J. Gen. Physiol. 111, 679–690 (1998).
Article CAS PubMed PubMed Central Google Scholar
Zamudio, F. Z. et al. Primary structure and synthesis of imperatoxin A (IpTxa), a peptide activator of Ca2+ release channels/ryanodine receptors. FEBS Lett. 405, 385–389 (1997).
Article CAS PubMed Google Scholar
Dulhunty, A. F., Hewawasam, R., Liu, D., Casarotto, M. G. & Board, P. G. Regulation of the cardiac muscle ryanodine receptor by glutathione transferases. Drug Metab. Rev. 43, 236–252 (2011).
Article CAS PubMed Google Scholar
Iyer, K. A. et al. Structural mechanism of two gain-of-function cardiac and skeletal RyR mutations at an equivalent site by cryo-EM. Sci. Adv. 6, eabb2964 (2020).
Article ADS CAS PubMed PubMed Central Google Scholar
Woll, K. A., Haji-Ghassemi, O., Van & Petegem, F. Pathological conformations of disease mutant ryanodine receptors revealed by cryo-EM. Nat. Commun. 12, 807 (2021).
Article ADS CAS PubMed PubMed Central Google Scholar
Ren, G., Ke, N. & Berkmen, M. Use of the SHuffle strains in production of proteins. Curr. Protoc. Protein Sci. 85, 5 26 21–25 26 21 (2016).
Article Google Scholar
Ahern, G. P., Junankar, P. R. & Dulhunty, A. F. Single-channel activity of the ryanodine receptor calcium-release channel is modulated by Fk-506. Febs Lett. 352, 369–374 (1994).
Article CAS PubMed Google Scholar
Sitsapesan, R., McGarry, S. J. & Williams, A. J. Cyclic ADP-ribose competes with ATP for the adenine nucleotide binding site on the cardiac ryanodine receptor Ca(2+)-release channel. Circ. Res 75, 596–600 (1994).
Article CAS PubMed Google Scholar
Gallant, E. M., Curtis, S., Pace, S. M. & Dulhunty, A. F. Arg615Cys substitution in pig skeletal ryanodine receptors increases activation of single channels by a segment of the skeletal DHPR II-III Loop. Biophys. J. 80, 1769–1782 (2001).
Article CAS PubMed PubMed Central Google Scholar
Mobli, M., Maciejewski, M. W., Gryk, M. R. & Hoch, J. C. An automated tool for maximum entropy reconstruction of biomolecular NMR spectra. Nat. Methods 4, 467–468 (2007).
Article CAS PubMed Google Scholar
Vranken, W. F. et al. The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins 59, 687–696 (2005).
Article CAS PubMed Google Scholar
Shen, Y. & Bax, A. Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks. J. Biomol. NMR 56, 227–241 (2013).
Article CAS PubMed PubMed Central Google Scholar
Guntert, P. & Buchner, L. Combined automated NOE assignment and structure calculation with CYANA. J. Biomol. NMR 62, 453–471 (2015).
Article PubMed Google Scholar
Mobli, M. & King, G. F. NMR methods for determining disulfide-bond connectivities. Toxicon 56, 849–854 (2010).
Article CAS PubMed Google Scholar
Nasr, M. L. et al. Covalently circularized nanodiscs for studying membrane proteins and viral entry. Nat. Methods 14, 49–52 (2017).
Article CAS PubMed Google Scholar
Hagn, F., Nasr, M. L. & Wagner, G. Assembly of phospholipid nanodiscs of controlled size for structural studies of membrane proteins by NMR. Nat. Protoc. 13, 79–98 (2018).
Article CAS PubMed Google Scholar
Camacho, C. et al. BLAST+: architecture and applications. BMC Bioinforma. 10, 421 (2009).
Article Google Scholar
Undheim, E. A. B. & Jenner, R. A. Phylogenetic analyses suggest centipede venom arsenals were repeatedly stocked by horizontal gene transfer. Nat. Commun. 12, 818 (2021).
Article ADS CAS PubMed PubMed Central Google Scholar
Dash, T. S. et al. A centipede toxin family defines an ancient class of Csalphabeta defensins. Structure 27, 315–326 e317 (2019).
Article CAS PubMed Google Scholar
Mistry, J., Finn, R. D., Eddy, S. R., Bateman, A. & Punta, M. Challenges in homology search: HMMER3 and convergent evolution of coiled-coil regions. Nucleic Acids Res. 41, e121 (2013).
Article CAS PubMed PubMed Central Google Scholar
Li, W. & Godzik, A. Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinforma. (Oxf., Engl.) 22, 1658–1659 (2006).
CAS Google Scholar
Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772–780 (2013).
Article CAS PubMed PubMed Central Google Scholar
Kalyaanamoorthy, S., Minh, B. Q., Wong, T. K. F., von Haeseler, A. & Jermiin, L. S. ModelFinder: fast model selection for accurate phylogenetic estimates. Nat. Methods 14, 587–589 (2017).
Article CAS PubMed PubMed Central Google Scholar
Nguyen, L. T., Schmidt, H. A., von Haeseler, A. & Minh, B. Q. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol. Biol. Evol. 32, 268–274 (2015).
Article CAS PubMed Google Scholar
Hoang, D. T., Chernomor, O., von Haeseler, A., Minh, B. Q. & Vinh, L. S. UFBoot2: improving the ultrafast bootstrap approximation. Mol. Biol. Evol. 35, 518–522 (2018).
Article CAS PubMed Google Scholar
Han, M. V. & Zmasek, C. M. phyloXML: XML for evolutionary biology and comparative genomics. BMC Bioinforma. 10, 356 (2009).
Article Google Scholar
Shafee, T. & Anderson, M. A. A quantitative map of protein sequence space for the cis-defensin superfamily. Bioinforma. (Oxf., Engl.) 35, 743–752 (2019).
CAS Google Scholar

Download references

Acknowledgements

We thank the Queensland NMR Network for providing access to its 900-MHz NMR spectrometer. This work was supported by National Health and Medical Research Council (Australian) Project grant APP1162597 (M.M.). National Health and Medical Research Council (Australian) Career Development Fellowship APP1137011 (I.V.), Australian Research Council Discovery grant DP190101177 (M.M. and E.A.B.U.), Norwegian Research Council FRIPRO-YRT Fellowship no. 287462 (E.A.B.U.) and the University of Queensland Postgraduate Research Scholarship (M.J.M.), NSW Health infrastructure grant through the Hunter Medical Research Institute (D.R.L.).

Author information

Chris Thekkedam
Present address: Developmental and Regenerative Biology Division, Victor Chang Cardiac Research Institute, Darlinghurst, NSW, 2010, Australia

Authors and Affiliations

Centre for Advanced Imaging, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, QLD, 4072, Australia
Michael J. Maxwell, Yanni K.-Y. Chin, Theo Crawford, Junyu Liu, Xinying Jia, Eivind A. B. Undheim & Mehdi Mobli
Eccles Institute of Neuroscience, John Curtin School of Medical Research, Australian National University, Canberra, ACT, 2601, Australia
Chris Thekkedam & Angela Dulhunty
School of Biomedical Sciences, The University of Queensland, St. Lucia, QLD, 4072, Australia
Cedric Lamboley & Bradley S. Launikonis
Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD, 4072, Australia
Jennifer J. Smith & Irina Vetter
School of Pharmacy, The University of Queensland, Woolloongabba, Australia
Irina Vetter
School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, 2308, Australia
Derek R. Laver
Centre for Ecological and Evolutionary Synthesis, Department of Biosciences, University of Oslo, 0316, Oslo, Norway
Eivind A. B. Undheim

Authors

Michael J. Maxwell
View author publications
You can also search for this author in PubMed Google Scholar
Chris Thekkedam
View author publications
You can also search for this author in PubMed Google Scholar
Cedric Lamboley
View author publications
You can also search for this author in PubMed Google Scholar
Yanni K.-Y. Chin
View author publications
You can also search for this author in PubMed Google Scholar
Theo Crawford
View author publications
You can also search for this author in PubMed Google Scholar
Jennifer J. Smith
View author publications
You can also search for this author in PubMed Google Scholar
Junyu Liu
View author publications
You can also search for this author in PubMed Google Scholar
Xinying Jia
View author publications
You can also search for this author in PubMed Google Scholar
Irina Vetter
View author publications
You can also search for this author in PubMed Google Scholar
Derek R. Laver
View author publications
You can also search for this author in PubMed Google Scholar
Bradley S. Launikonis
View author publications
You can also search for this author in PubMed Google Scholar
Angela Dulhunty
View author publications
You can also search for this author in PubMed Google Scholar
Eivind A. B. Undheim
View author publications
You can also search for this author in PubMed Google Scholar
Mehdi Mobli
View author publications
You can also search for this author in PubMed Google Scholar

Contributions

M.M. and E.A.B.U. conceived of and directed the research with input from M.J.M. Molecular cloning of Xt3a variants was performed by X.J. Recombinant expression and purification of peptides was done by M.J.M. with support from T.C. Production, assembly, and NMR titrations of circularised nanodiscs with Xt3a was performed by Y.K.Y.C. with support from M.J.M. Collection of NMR data for structure determination was done by M.M. Structure determination was performed by M.J.M., M.M. and Y.K.C. NMR relaxation data were acquired by M.M. and processed by M.J.M. Electrophysiology experiments were performed by A.D., C.T. and D.R.L. Quantification of total Ca²⁺ content in muscle fiber experiments were conducted by C.L. with support from B.S.L. Functional characterisation including ion channel FLIPR assays were performed by J.J.S. and I.V. Datamining and evolutionary analyses were performed by E.A.B.U. and J.L. Initial manuscript was written by M.J.M. with input from M.M. and E.A.B.U. All authors contributed to finalising the manuscript.

Corresponding authors

Correspondence to Eivind A. B. Undheim or Mehdi Mobli.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Communications thanks the anonymous reviewers for their contribution to the peer review of this work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information

Description of Additional Supplementary Files

Supplementary Data 1

Supplementary Data 2

Reporting Summary

Source data

Source Data

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Cite this article

Maxwell, M.J., Thekkedam, C., Lamboley, C. et al. A bivalent remipede toxin promotes calcium release via ryanodine receptor activation. Nat Commun 14, 1036 (2023). https://doi.org/10.1038/s41467-023-36579-w

Download citation

Received: 09 February 2022
Accepted: 07 February 2023
Published: 23 February 2023
DOI: https://doi.org/10.1038/s41467-023-36579-w

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.